Mit Holding Inc (CVAH) Financial Statements (2024 and earlier)

Company Profile

Business Address 11835 WEST OLYMPIC BLVD
LOS ANGELES, CA 90064
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2015
MRQ
12/31/2014
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 453
Cash and cash equivalents 453
Receivables 208236
Inventory, net of allowances, customer advances and progress billings  143
Inventory  143
Prepaid expense and other current assets47
Other undisclosed current assets  1
Total current assets: 212480
Noncurrent Assets
Property, plant and equipment 727
Intangible assets, net (including goodwill)  (200)
Intangible assets, net (excluding goodwill)  (200)
Other undisclosed noncurrent assets 400596
Total noncurrent assets: 407423
TOTAL ASSETS: 619904
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 2,8602,754
Other undisclosed accounts payable and accrued liabilities 2,8602,754
Debt 1,691337
Total current liabilities: 4,5503,091
Noncurrent Liabilities
Long-term debt and lease obligation  954
Long-term debt, excluding current maturities  954
Liabilities, other than long-term debt 250250
Financial instruments subject to mandatory redemption, settlement terms, share value, amount 250250
Other undisclosed noncurrent liabilities (485)20
Total noncurrent liabilities: (235)1,224
Total liabilities: 4,3154,315
Equity
Equity, attributable to parent, including: (4,088)(3,411)
Common stock 00
Additional paid in capital 8,6937,582
Accumulated deficit (12,781)(10,994)
Other undisclosed equity, attributable to parent 0 
Other undisclosed equity 392 
Total equity: (3,696)(3,411)
TOTAL LIABILITIES AND EQUITY: 619904

Income Statement (P&L) ($ in thousands)

9/30/2015
TTM
12/31/2014
12/31/2012
Revenues
(Revenue, Net)
 1,0833,356
Cost of revenue
(Cost of Goods and Services Sold)
 (305)(1,516)
Gross profit: 7781,840
Operating expenses (763)(4,542)
Other undisclosed operating income  1,781
Operating income (loss): 14(922)
Interest and debt expense (241)(195)
Loss from continuing operations before equity method investments, income taxes: (227)(1,116)
Other undisclosed loss from continuing operations before income taxes  (20)
Loss from continuing operations: (227)(1,137)
Loss before gain (loss) on sale of properties: (227)(1,137)
Net loss available to common stockholders, diluted: (227)(1,137)

Comprehensive Income ($ in thousands)

9/30/2015
TTM
12/31/2014
12/31/2012
Net loss: (227)(1,137)
Comprehensive loss, net of tax, attributable to parent: (227)(1,137)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: